SANTEN PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss
The total revenue of 4536/N for the last quarter is 8.66 B MXN, and it's 6.55% lower compared to the previous quarter. The net income of Q4 23 is 3.28 M MXN.